DexefaroxanAlternative Names: L0046
Latest Information Update: 24 Apr 2007
At a glance
- Originator Pierre Fabre
- Class Antiparkinsonians; Benzopyrans; Imidazoles; Neuroprotectants; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alzheimer's disease; Cognition disorders